Inspire Medical Systems, Inc.
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Nov 2, 2026 (7 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Oct 7, 2026 | Barclays | initiate | — → Underweight | — | 53% |
| Oct 2, 2026 | Freedom Capital Markets | maintain | Buy → Buy | — | 43% |
| Oct 1, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Sep 21, 2026 | Freedom Capital Markets | maintain | Buy → Buy | — | 43% |
| Sep 11, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Aug 4, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Aug 4, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Aug 4, 2026 | Oppenheimer | upgrade | Perform → Outperform | — | 52% |
| Aug 4, 2026 | Truist Securities | reiterate | Hold → Hold | — | 54% |
| Aug 4, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Aug 4, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Aug 4, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jul 16, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 1, 2026 | Freedom Capital Markets | initiate | — → Buy | — | 43% |
| Jun 23, 2026 | Evercore ISI Group | downgrade | Outperform → In-Line | — | 58% |
| May 7, 2026 | Oppenheimer | maintain | Perform → Perform | — | 52% |
| May 5, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| May 5, 2026 | Piper Sandler | downgrade | Overweight → Neutral | — | 54% |
| May 5, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| May 5, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| May 5, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| May 5, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 5, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 5, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 5, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Apr 15, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 10, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 5, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Feb 13, 2026 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 53% |
| Feb 12, 2026 | Jefferies | maintain | Hold → Hold | $66 | 52% |
| Feb 12, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | $68 | 55% |
| Feb 12, 2026 | Piper Sandler | maintain | Overweight → Overweight | $85 | 54% |
| Feb 12, 2026 | Truist Securities | maintain | Hold → Hold | $70 | 54% |
| Feb 12, 2026 | Mizuho | maintain | Outperform → Outperform | $85 | 52% |
| Feb 12, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | $70 | 54% |
| Feb 12, 2026 | Baird | downgrade | Outperform → Neutral | $74 | 55% |
| Jan 27, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | $90 | 55% |
| Jan 14, 2026 | Wells Fargo | maintain | Overweight → Overweight | $145 | 54% |
| Jan 8, 2026 | Truist Securities | maintain | Buy → Buy | $120 | 54% |
| Dec 23, 2025 | UBS | maintain | Neutral → Neutral | $91 | 54% |
| Dec 17, 2025 | RBC Capital | maintain | Outperform → Outperform | $175 | 55% |
| Dec 17, 2025 | Mizuho | maintain | Outperform → Outperform | $130 | 52% |
| Dec 16, 2025 | JP Morgan | maintain | Neutral → Neutral | $118 | 54% |
| Dec 8, 2025 | Piper Sandler | maintain | Overweight → Overweight | $165 | 54% |
| Dec 8, 2025 | Oppenheimer | upgrade | Perform → Outperform | $175 | 52% |
| Dec 4, 2025 | Baird | maintain | Outperform → Outperform | $180 | 55% |
| Dec 2, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $130 | 54% |
No cross-platform signals in the last 90 days